Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
06/19/2003 | US20030114419 Taxane derivatives having a tricyclic or tetracyclic core; remarkable properties in vitro; valuable antileukemia, antitumor and anticarcinogenic agents; human cancer cell line comparable to that of taxol and taxotere |
06/19/2003 | US20030114311 Such as 5,6-dichloropyridine-2-carboxylic acid-N-oxide for preemergence application |
06/19/2003 | US20030113643 Electrophotographic organophotoreceptors with novel charge transport materials |
06/19/2003 | US20030113132 Charge transport compounds of hydrazone substituted carbazole derivatives, a charge generating compound and electroconductive substrate |
06/19/2003 | US20030111956 Hexasubstituted benzene compounds are useful as hole transporting, green-light-emitting molecules with high glass transition temperature |
06/19/2003 | CA2470111A1 Production of chirally pure .alpha.-amino acids and n-sulfonyl .alpha.-amino acids |
06/19/2003 | CA2469316A1 Pyrimidine-based compounds useful as gsk-3 inhibitors |
06/19/2003 | CA2468544A1 Vanilloid receptor ligands |
06/18/2003 | EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors |
06/18/2003 | EP1318995A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
06/18/2003 | EP1318985A2 4-amino-quinazolines |
06/18/2003 | EP1318984A1 4-amino-quinazolines |
06/18/2003 | EP1318981A2 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor |
06/18/2003 | EP1318980A2 Hydroxamate derivatives useful as deacetylase inhibitors |
06/18/2003 | EP1318814A2 Triazole compounds useful as protein kinase inhibitors |
06/18/2003 | EP1075475B1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production |
06/18/2003 | CN1425018A Novel chromophores for polymeric thin films and optical waveguide and devices comprising the same |
06/18/2003 | CN1425013A Phenyl substituted 4-hydroxy tetrahydropyridone |
06/18/2003 | CN1425012A Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme IKK-2 |
06/18/2003 | CN1425008A 3-aminoquinazolin-2, 4-dione antibacterial agents |
06/18/2003 | CN1111529C Piperazino derivatives as neurokinin antagonists |
06/18/2003 | CN1111528C Piperazino derivatives as neurokinin antagonists |
06/17/2003 | US6579983 5-cyano-2-aminopyrimidine derivatives |
06/17/2003 | US6579894 Bactericides, fungicides |
06/17/2003 | US6579892 Affective disorders; neurotic, stress and somatoform disorders and psychoses, e.g. schizophrenia 3-(3-(6-Methyl-1,2,3,4-tetrahydronaphth-2-ylamino)propylmercap to) -4-methyl-5-phenyl-1,2,4(4H)-triazole |
06/17/2003 | US6579885 For therapy of attention deficit disorder, hyperactivity disorder, anxiety, depression, post-traumatic stress disorder, supranuclear palsy, eating disorders, obsessive compulsive disorder, analgesia, nicotine addiction, Parkinsonism |
06/17/2003 | US6579879 For therapy of diabetic neuropathy, diabetic retinopathy, diabetic nephropathy, diabetic cardiomyopathy, diabetic microangiopathy and diabetic macroangiopathy in mammals |
06/17/2003 | US6579874 Substituted azoles |
06/17/2003 | US6579823 Group 8-10 metal complex comprising a bidentate or variable denticity ligand; polymerization of olefins |
06/12/2003 | WO2003048156A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |
06/12/2003 | WO2003048133A1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i) |
06/12/2003 | WO2003048129A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
06/12/2003 | WO2003048125A1 Aminotetralin derivatives as muscarinic receptor antagonists |
06/12/2003 | WO2003048124A1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
06/12/2003 | WO2003048123A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
06/12/2003 | WO2003048122A2 Inhibitors of cytosolic phospholipase a2 |
06/12/2003 | WO2003048118A1 5-ht7 receptor antagonists |
06/12/2003 | WO2003047626A1 Use of a glucokinase activator in combination with a glucagon antagonist for treating type 2 diabetes |
06/12/2003 | WO2003047586A1 Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer |
06/12/2003 | WO2003047577A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
06/12/2003 | WO2003047568A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
06/12/2003 | WO2003047508A2 Paclitaxel solvates |
06/12/2003 | WO2003047347A1 Microbiocidal n-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives |
06/12/2003 | US20030109706 Serine pretease inhibitors |
06/12/2003 | US20030109564 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
06/12/2003 | US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds |
06/12/2003 | US20030109551 A therapeutic or preventive agent for pulmonary insufficiency, containing as an active ingredient a diaminotrifluoromethylpyridine derivative represented by the formula (I) or its salt: anti-inflammatory agent or an anti- |
06/12/2003 | US20030109538 Pyrmidine derivatives as selective inhibitors of cox-2 |
06/12/2003 | US20030109533 New benzenesulphonamide compounds |
06/12/2003 | US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists |
06/12/2003 | US20030109518 Substituted 1,4-benzodiazepines and uses thereof |
06/12/2003 | US20030109517 Azacycloalkanone serine protease inhibitors |
06/12/2003 | US20030107027 Second order nonlinear optical chromophores and electro-optic devices therefrom |
06/12/2003 | CA2469385A1 Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them |
06/12/2003 | CA2468996A1 Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer |
06/12/2003 | CA2468967A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
06/12/2003 | CA2467435A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
06/11/2003 | EP1318149A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing them |
06/11/2003 | EP1318147A1 Novel pyrimidine derivative and novel pyridine derivative |
06/11/2003 | EP1318140A1 Novel amide derivatives and medicinal use thereof ugs |
06/11/2003 | EP1317490A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
06/11/2003 | EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors |
06/11/2003 | EP1317451A1 Chemokine receptor binding heterocyclic compounds |
06/11/2003 | EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors |
06/11/2003 | EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors |
06/11/2003 | EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors |
06/11/2003 | EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors |
06/11/2003 | EP1317445A2 Chemokine receptor binding heterocyclic compounds |
06/11/2003 | EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors |
06/11/2003 | EP1317442A1 Quinolinone derivatives as tyrosine kinase inhibitors |
06/11/2003 | EP1317433A2 Inhibitors of glycogen synthase kinase 3 |
06/11/2003 | EP1317428A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
06/11/2003 | EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents |
06/11/2003 | EP1317266A2 Neuroprotective 2-pyridinamine compositions and related methods |
06/11/2003 | EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
06/11/2003 | EP0996614B1 Acrylonitrile compounds, process for their production and pesticides containing them |
06/11/2003 | EP0956283B1 Substituted phenyltriazolin(thi)ones and their use as herbicides |
06/11/2003 | EP0611301B1 Chelator compositions comprising oxime compounds |
06/11/2003 | CN1423635A Nitrogenous compounds and antiviral drugs containing the same |
06/11/2003 | CN1423633A Azetidine derivatives, preparation thereof and pharmaceutical compositions |
06/11/2003 | CN1422849A 吲唑衍生物 Indazole derivative |
06/10/2003 | US6576771 Pesticides, herbicides and fungicides |
06/10/2003 | US6576656 Such as 1-(2-diethylaminoethyl)-4-trifluoromethyl-6-carbamoyl-3-hydroxy-3-(2 -chlorophenyl)oxindole; growth hormone releaser |
06/10/2003 | US6576621 Preparation of thioarabinofuranosyl compounds and use thereof |
06/10/2003 | US6576159 Colorants, electroconductive materials; solubility, dissociation |
06/10/2003 | CA2232775C Acyl compounds |
06/05/2003 | WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
06/05/2003 | WO2003045942A2 Chemokine receptor antagonists and methods of use thereof |
06/05/2003 | WO2003045941A1 Pyridine and pyrimidine derivatives |
06/05/2003 | WO2003045937A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor |
06/05/2003 | WO2003045926A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
06/05/2003 | WO2003045924A1 Substituted aryl 1,4-pyrazine derivatives |
06/05/2003 | WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors |
06/05/2003 | WO2003045918A1 Piperidine-based mch antagonists for treatment of obesity and cns disorders |
06/05/2003 | WO2003045385A1 Benzothiazole derivatives |
06/05/2003 | WO2003045379A1 Hydrazonopyrazole derivatives and their use as therapeutics |
06/05/2003 | WO2002048124A3 Piperazine derivatives |
06/05/2003 | US20030105343 Benzofuran compounds |
06/05/2003 | US20030105340 Reacting a isochroman-1,3-dione with a carbonyl compound whose carbonyl group is substituted with an acyl activating group, in the presence of a base and a solvent; use making anticancer agents for example |
06/05/2003 | US20030105336 Pyrazole derivatives, their preparation and their use in pharmaceuticals |